About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

1 1 (September 13, 2023)

handle is hein.crs/govemuz0001 and id is 1 raw text is: 







             Congressional                                                   ____
          ~   Research Service






Department of Health and Human Services

Recommendation to Reschedule Marijuana:

Implications for Federal Policy



September 13, 2023

On August 29, 2023, the Department of Health and Human Services (HHS) recommended to the Drug
Enforcement Administration (DEA) that marijuana be rescheduled from Schedule I to Schedule III under
the Controlled Substances Act (CSA). This recommendation is based on the Food and Drug
Administration's (FDA's) review of marijuana (as requested by President Biden in 2022) and related
findings that are not currently available to the public. DEA has testified in response to questioning at a
congressional hearing in 2020 that it is bound by FDA's recommendations on scientific and medical
matters, and if past is prologue it could be likely that DEA will reschedule marijuana according to HHS's
recommendation.
If marijuana is rescheduled to Schedule III, it would have broad implications for federal policy. Also, this
move would have significant implications for state medical marijuana programs and users of medical
marijuana, but fewer implications for state recreational marijuana programs and those who use marijuana
recreationally. This Insight discusses both the potential rescheduling and select policy implications.

Rescheduling Marijuana to Schedule III

The CSA classifies various substances in one of five schedules based on their medical use, potential for
abuse, and safety or risk of dependence. The five schedules are progressively ordered, with substances
regarded as the least dangerous and addictive controlled in Schedule V and those considered the most
dangerous and addictive controlled in Schedule I.

Marijuana  as a Schedule  I Controlled Substance
As described in the CSA, Schedule I substances have a high potential for abuse with no currently
accepted medical use in treatment in the United States and cannot safely be dispensed under a
prescription. As a Schedule I controlled substance, the CSA prohibits the manufacture, distribution,
dispensation, and possession of marijuana except for federal government-approved research studies. The


                                                             Congressional Research Service
                                                             https://crsreports.congress.gov
                                                                                 IN12240

CRS INSIGHT
Prepared for Members and
Committees of Congress

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most